Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2015 2
2016 3
2017 1
2018 1
2019 3
2020 1
2021 1
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
CRISPR/Cas9-Based Cellular Engineering for Targeted Gene Overexpression.
Osborn MJ, Lees CJ, McElroy AN, Merkel SC, Eide CR, Mathews W, Feser CJ, Tschann M, McElmury RT, Webber BR, Kim CJ, Blazar BR, Tolar J. Osborn MJ, et al. Among authors: mcelroy an. Int J Mol Sci. 2018 Mar 22;19(4):946. doi: 10.3390/ijms19040946. Int J Mol Sci. 2018. PMID: 29565806 Free PMC article.
TALEN-based gene correction for epidermolysis bullosa.
Osborn MJ, Starker CG, McElroy AN, Webber BR, Riddle MJ, Xia L, DeFeo AP, Gabriel R, Schmidt M, von Kalle C, Carlson DF, Maeder ML, Joung JK, Wagner JE, Voytas DF, Blazar BR, Tolar J. Osborn MJ, et al. Among authors: mcelroy an. Mol Ther. 2013 Jun;21(6):1151-9. doi: 10.1038/mt.2013.56. Epub 2013 Apr 2. Mol Ther. 2013. PMID: 23546300 Free PMC article.
Fanconi anemia gene editing by the CRISPR/Cas9 system.
Osborn MJ, Gabriel R, Webber BR, DeFeo AP, McElroy AN, Jarjour J, Starker CG, Wagner JE, Joung JK, Voytas DF, von Kalle C, Schmidt M, Blazar BR, Tolar J. Osborn MJ, et al. Among authors: mcelroy an. Hum Gene Ther. 2015 Feb;26(2):114-26. doi: 10.1089/hum.2014.111. Hum Gene Ther. 2015. PMID: 25545896 Free PMC article.
CRISPR/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosa.
Webber BR, Osborn MJ, McElroy AN, Twaroski K, Lonetree CL, DeFeo AP, Xia L, Eide C, Lees CJ, McElmurry RT, Riddle MJ, Kim CJ, Patel DD, Blazar BR, Tolar J. Webber BR, et al. Among authors: mcelroy an. NPJ Regen Med. 2016;1:16014-. doi: 10.1038/npjregenmed.2016.14. Epub 2016 Dec 8. NPJ Regen Med. 2016. PMID: 28250968 Free PMC article.
Disruption of HIV-1 co-receptors CCR5 and CXCR4 in primary human T cells and hematopoietic stem and progenitor cells using base editing.
Knipping F, Newby GA, Eide CR, McElroy AN, Nielsen SC, Smith K, Fang Y, Cornu TI, Costa C, Gutierrez-Guerrero A, Bingea SP, Feser CJ, Steinbeck B, Hippen KL, Blazar BR, McCaffrey A, Mussolino C, Verhoeyen E, Tolar J, Liu DR, Osborn MJ. Knipping F, et al. Among authors: mcelroy an. Mol Ther. 2022 Jan 5;30(1):130-144. doi: 10.1016/j.ymthe.2021.10.026. Epub 2021 Nov 2. Mol Ther. 2022. PMID: 34737067 Free PMC article.
Base Editor Correction of COL7A1 in Recessive Dystrophic Epidermolysis Bullosa Patient-Derived Fibroblasts and iPSCs.
Osborn MJ, Newby GA, McElroy AN, Knipping F, Nielsen SC, Riddle MJ, Xia L, Chen W, Eide CR, Webber BR, Wandall HH, Dabelsteen S, Blazar BR, Liu DR, Tolar J. Osborn MJ, et al. Among authors: mcelroy an. J Invest Dermatol. 2020 Feb;140(2):338-347.e5. doi: 10.1016/j.jid.2019.07.701. Epub 2019 Aug 19. J Invest Dermatol. 2020. PMID: 31437443 Free PMC article.
CRISPR/Cas9 Targeted Gene Editing and Cellular Engineering in Fanconi Anemia.
Osborn M, Lonetree CL, Webber BR, Patel D, Dunmire S, McElroy AN, DeFeo AP, MacMillan ML, Wagner J, Balzar BR, Tolar J. Osborn M, et al. Among authors: mcelroy an. Stem Cells Dev. 2016 Oct;25(20):1591-1603. doi: 10.1089/scd.2016.0149. Epub 2016 Aug 18. Stem Cells Dev. 2016. PMID: 27538887 Free PMC article.
12 results